According to Merck's latest financial reports the company's total debt is $35.05 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $35.05 B | 14.22% |
2022-12-31 | $30.69 B | -7.28% |
2021-12-31 | $33.10 B | 4.12% |
2020-12-31 | $31.79 B | 20.67% |
2019-12-31 | $26.34 B | 4.91% |
2018-12-31 | $25.11 B | 2.88% |
2017-12-31 | $24.41 B | -1.74% |
2016-12-31 | $24.84 B | -5.94% |
2015-12-31 | $26.41 B | 23.4% |
2014-12-31 | $21.40 B | -14.59% |
2013-12-31 | $25.06 B | 21.83% |
2012-12-31 | $20.56 B | 17.44% |
2011-12-31 | $17.51 B | -2.05% |
2010-12-31 | $17.88 B | 2.33% |
2009-12-31 | $17.47 B | 180.01% |
2008-12-31 | $6.24 B | 8.73% |
2007-12-31 | $5.73 B | -16.04% |
2006-12-31 | $6.83 B | -15.58% |
2005-12-31 | $8.09 B | 17.82% |
2004-12-31 | $6.87 B | 1.13% |
2003-12-31 | $6.79 B | -20.5% |
2002-12-31 | $8.54 B | -3.57% |
2001-12-31 | $8.86 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $33.63 B | -4.06% | ๐บ๐ธ USA |
Novartis NVS | $27.28 B | -22.17% | ๐จ๐ญ Switzerland |
Pfizer PFE | $70.84 B | 102.10% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $15.62 B | -55.42% | ๐บ๐ธ USA |
Eli Lilly LLY | $26.21 B | -25.23% | ๐บ๐ธ USA |
Amgen AMGN | $64.61 B | 84.32% | ๐บ๐ธ USA |
Sanofi SNY | $20.36 B | -41.90% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $57.40 B | 63.77% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $22.45 B | -35.93% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $20.15 B | -42.51% | ๐ฎ๐ฑ Israel |